share_log

威高骨科(688161.SH):运动医学集采不会对新生医疗业绩造成影响

Weigao Orthopedics (688161.SH): The centralized procurement of sports medicine will not affect the performance of its newly established medical business.

Gelonghui Finance ·  Jun 12 08:11

On June 12th, Gelonhui reported that Weigao Orthopedics (688161.SH) stated on the investor interactive platform that the national sports medical collection will land this year. Newborn Medical's main business is in the field of tissue repair, with its main products being PRP and negative pressure drain kits. The sports medical collection will not have an impact on the performance of Newborn Medical.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment